The natural product cyclic peptide stylissatin A (1a), was reported to inhibit nitric oxide production in LPS-stimulated murine macrophage RAW 264.7 cells. In the current study, solidphase total synthesis of stylissatin A was performed by using a safety-catch linker and yielded the peptide with a trans-Pro 6 -Phe 7 linkage whereas the natural product is the trans rotamer at this position as evidenced by a marked difference in NMR chemical shifts. In order to preclude the possibility of 1b beingan epimer of the natural product, we repeated the synthesis using D-allo- production. The analogues 2-7 weakly inhibited NO . production, but strongly inhibited IL-2 cytokine production compared to synthetic peptide 1b. All analogues inhibited the proliferation of T-cells, with analogue 7 having the strongest effect. In the analogues, the Pro 6 residue was replaced by Glu/Ala and the SAR indicates that the nature of this residue plays a role in the biological function of these peptides.
Inhibition of IL-2 provides a strong immunosuppressive response by preventing the activation and proliferation of T-cells in transplantation rejection and other autoimmune diseases [8] .
Given the interesting structure of stylissatin A (1a) with the inclusion of two proline residues that can exist as cis or trans rotamers and the biological activity in reducing NO . release, we embarked on investigations to complete the total synthesis of stylissatin A and a set of analogues to explore structure-activity relationships. During the course of our study, the synthesis of stylissatin A was reported by a combination of solid and solution-phase synthesis and the synthetic sample also exhibited strong inhibition against NO . release (EC50 73 µM) [9] . Although the proline rotatmers of the synthetic and natural stylissatin A were not assigned, analysis of the reported 13 CNMR data indicates that both are the trans, cis proline rotamers with a trans-peptide bond between Pro 4 -Ile 5 and a cis-peptide bond between Pro 6 -Phe 7 .
RESULTS AND DISCUSSION:
Among various synthetic methods to cyclic peptides, the on-resin cyclization approach has been successfully employed in the synthesis of several biologically active natural peptides. Several procedures have been developed for on-resin cyclization in good yields with minimum side products [10] [11] [12] . For the synthesis of peptide 1, we selected Kenner's sulfonamide safety-catch linker strategy as employed previously for cyclic peptides by others [13] [14] [15] [16] as well as ourselves [17] [18] [19] . In our first synthesis (route A), Fmoc-L-isoleucine was employed for loading on the sulphamylbutyryl Kenner safety-catch resin. Using Fmoc solid-phase peptide synthesis, the head-to-tail coupling of amino acids was carried out to produce the linear peptide precursor of 1.
The Fmoc group of the terminal amino acid Tyr was replaced by Boc before activation of the safety-catch linker through alkylation with iodoacetonitrile. The Boc group was then removed by using a TFA cocktail. Base treatment promoted on-resin macrocyclization between Ile and Tyr residues of the linear precursor to produce the cyclic peptide 1b which was simultaneously cleaved from the resin (Scheme 1).
Reverse-phase recycling HPLC with an isocratic solvent system was used in the purification of the major product 1b. A comparison of NMR chemical shifts of natural stylissatin 1a and synthetic peptide 1b in d6-DMSO were performed ( Our results combined with the previous synthesis [9] indicate the proline rotamer population can be significantly influenced by the macrocyclization method used.
In route A, since the isoleucine residue was activated and involved in the macrocyclization step, another possible explanation is that the differences in chemical shifts between 1a and 1b may be due to epimerization at Ile 2 during macrocyclization [9] . In order to preclude the possibility of 1b as an epimer of the natural product, we carried out a second synthesis (route B) in which the macrocyclization was taking place at a different position between tyrosine and phenylalanine residues (Scheme 2). Furthermore, in this synthesis, we deliberately replaced L-Ile 2 by D-alloIle 2 to ensure full epimerization at this position. Afterh this synthesis, the peptide 1c was purified and analyzed by reverse-phase high performance liquid chromatography. It showed a different retention time (Figure 2 ) and distinct 1 HNMR data compared to 1b ( Figure S9 ).Although both 1b and 1c contain trans proline rotamers, they were distinct species and this confirms that 1b is in fact a proline rotamer of natural stylissatin A (1a) rather than an epimer at the Ile 2 residue (Table-1 ).
The synthesis of stylissatin A was then performed using route B (Scheme 3) with L-Ile 2 to investigate whether the site of cyclization affects the rotamer populationDespite the different position of macrocyclization, the synthesis one again afforded the trans, trans proline rotamer 1b as the major product as determined by HPLC and NMR comparison with the sample from route ANevertheless, a small amount of a second product was obtained that we were able to isolate and spectroscopically characterize as identical to the trans, cis natural product rotamer 1a( Table-1 Many proline-rich synthetic cyclic peptides such as stylopeptides, axinastins and cherimolacyclopeptide E have not reproduced the biological activity reported forthe naturally isolated material [19, 24] . One reason for this discrepancy is cis / trans isomerization at proline linkages in such peptides having an effect on the bioactivity [24] . In the current study, despite the rotamer difference, our synthetic sample of stylissatin A 1a and its rotamer 1b show similar nitric oxide inhibitory activity. This reveals that the cis / trans conformation of the Pro 6 residue in stylissatin A has no impact on biological activity of these peptides.
In order to better understand the structure-activity relationships of stylissatin A, we embarked on the synthesis of six analogues 2-7 (Table- 2) (Scheme 4). Given the potential for multiple rotamers with the safety-catch strategy, we switched to an on-resin cyclization approach using the Wang resin [25] [26] [27] [28] . Linear precursors of peptide analogues were anchored to the Wang resin through the side chain of glutamic acid. Fmoc-peptide coupling and Fmoc group deprotection followed standard procedures that were used in the natural product synthesis. After the synthesis of the linear chain, the allyl protecting group of the Glu residue was removed by using palladium (0) (Scheme 1). The Fmoc group of the terminal amino acid residue was removed by 4-methylpiperidine in DMF. On-resin cyclization (27-29) was carried out by using
Oxymapure / DIC and a TFA cocktail cleaved the final product from the resin. The structures of analogues were confirmed by MALDI (Table S1 ) and NMR studies (Table 3,4) . Purification of all peptides was achieved by using preparative HPLC.
The peptide 1b and related six analogues 2-7 were evaluated for their anti-inflammatory potential by investigating different immune parameters including effects on production of NO . , intracellular ROS and interleukin 2 (IL-2) cytokine (Table 5) Further investigations were focused on peptide 1b and its related analogues 2-7. No inhibition was observed when 1b was tested for its effect on ROS produced from whole blood and isolated neutrophils from the blood of healthy human volunteers. The peptide showed strong inhibitory effect against proliferation of T-cells whereas it moderately inhibited the production of cytokine interleukin 2 (IL-2) ( Table-5 ).
The analogues 2-7 showed weak inhibitory activity of NO . and more potent inhibition of interleukin 2 production compared to parent peptide 1. The common difference among the peptide sequence of natural peptide 1 and 2-7 is that Pro 6 is replaced by other amino acid residues in all analogues. That resulted in varying biological activity of natural peptide and its analogues (Table 5 ). It also appeared that by substitution of both proline residues (Pro 4 and Pro 6 )
of peptide 1, with Ala and Glu respectively, the resulting peptide analogue 2 was found to be a strong inhibitor of ROS with no inhibition of NO . . It potently inhibited ROS from neutrophils as well as strongly inhibited the release of cytokine interleukin 2 (IC50 13.4 ± 0.1 μM) (Table 5 ).
This indicated that both proline residues are involved in the mechanism of NO . inhibition. The peptide analogue 7, in which Ile 2 and Pro 6 were replaced by Ala and Glu, respectively, was found to be the most potent inhibitor of interleukin 2 (IC50 6.0 ± 0.9 μM) release among the peptides 1-7. The results obtained from current studies showed significant anti-inflammatory potential of synthetic peptide 1b and its analogues 2-7.
CONCLUSION
Stylissatin A (1a), proline rotamer of stylissatin A (1b), an epimer (1c) and six cyclic analogues 2-7 were successfully synthesized on solid-phase by employing different cyclization routes. All peptides were characterized by mass and NMR studies. The position of macrocyclization was found to influence the proline rotamer population of synthetic sytlissatin A. Synthetic stylissatin 1a was found to have similar activity to that reported in the literature. The synthetic stylissatin A 1a and its trans, trans rotamer 1b potently inhibited the NO . production. Analogue 2 inhibited ROS on whole blood, as well as neutrophils. Related analogues of stylissatin A were identified as more potent inhibitors of interleukin 2 release.
EXPERIMENTAL SECTION
General Experimental Procedures. Bruker 600 MHz NMR spectrometer were used for Proton and Carbon-13 NMR spectra. NMR data were collected at 25°C. ESI mass spectra were recorded on QSTAR XL MS/MS SYSTEMS (AB SCIEX, USA). Matrix-assisted laser desorption/ionization was carried out on Ultraflex III TOF/TOF (Bruker Daltonics, Bremen, Germany) mass spectrometer. Preparative RPHPLC separation was performed by using a Jaigel ODS-MAT 80 (C18) column using elution with acetonitrile / water (60:40) in 0.08 % TFA.
Optical rotation was measured with a JASCO DIP 360 polarimeter at the sodium D line (path length 50 mm).
Stylissatin A Synthesis. 4-Sulfamylbutyryl-aminomethyl resin (0.7 mmol/g) from Novabiochem and was used in the synthesis. Solid-phase synthesis was accomplished manually by using a stepwise Fmoc solid-phase peptide procedure. Agitations were performed with an orbital shaker or magnetic stirrer. Synthesis of linear peptidyl chain was achieved by applying same procedure as reported previously [16, 18, 19] .
Cleavage of Peptides from Resin after Cyclization. After activation of linker and removal of
Boc group from terminal amino acid as shown in scheme 1-3, the peptide resin was soaked in THF. It was then treated with 20 % DIEA / THF for 24 h in nitrogen atmosphere. The resin was filtered and washed with THF and DCM (3 × 25 mL each) and the filtrate was collected. After evaporation of solvents under reduced pressure, the crude cyclized product was precipitated with cold diethyl ether, and dried in vacuum. The crude peptides were precipitated from cold diethyl ether and further purified on RPHPLC. 
Synthesis of Stylissatin

IL-2 Production and Quantification:
Jurkat (human T lymphocyte leukemia) cells were maintained in RPMI-1640 (BioM Laboratories, Chemical Division, Malaysia) supplemented with 5% FBS and 1% penicillin / streptomycin (GIBCO New York U.S). Upon 70% confluency cells were plated in 96-well flat bottom plates (Costar, NY, USA) at a concentration of 2×10 6 cells/mL. The cells were activated by using 20 ng/mL of phorbol myristate acetate (PMA) and, 7.5 µg/mL of phytoheamagglutinin (PHA) (SERVA, Heidelberg, Germany). Cells were then treated with three different concentrations (2, 10, 50 μM) of compound and plate was incubated for 18 hours at 37 ºC in 5%
CO2. Supernatants were collected and IL-2 quantification was performed using the human IL-2
Kits Duo Set (R&D systems, Minneapolis, USA) and according to manufacturer's instructions
[32].
T-cell Proliferation Assay.
Cell proliferation assay performed by standard thymidine, incorporation assay [20] . Briefly, Tcells were isolated from peripheral blood of healthy volunteers using Ficoll paque method. The cells were plated at a concentration of 2 ×10 6 cells/mL in a round bottom 96-well tissue culture plates IWAKI (Chiba, Japan). Peptides were added in three different concentrations (2, 10 and 50 μM) in triplicates. The plates were then incubated for 48hrs at 37 °C in 5% CO2 incubator. 
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